Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Episode | Date |
---|---|
Zero to a billion... A CDMO original - part 2
|
May 03, 2024 |
Zero to a billion... A CDMO original - part 1
|
Apr 26, 2024 |
Dan’s the man...at Custom Biologics
|
Apr 19, 2024 |
Celebrating female talent in life sciences
|
Apr 05, 2024 |
The power of peptides
|
Mar 28, 2024 |
From Pfizer to CDMO carve-out
|
Mar 22, 2024 |
One-hour special: Meet the next big thing in obesity
|
Mar 15, 2024 |
M&A Roundtable and 2024 Predictions
|
Mar 08, 2024 |
Transforming a family pharma firm
|
Mar 01, 2024 |
From MassBio... to the world
|
Feb 23, 2024 |
From banking to biotech
|
Feb 16, 2024 |
Dealing with downturns... and the menopause.
|
Feb 09, 2024 |
The dealmaker now redefining commercialization
|
Feb 02, 2024 |
The biotech CDMO planning to impact the US
|
Jan 26, 2024 |
Molecule to Market: Our top trends 2023; part 2
|
Jan 19, 2024 |
Outsourcing in Ontario - on the cusp of greatness
|
Jan 12, 2024 |
Discover Diana of Dalriada
|
Jan 05, 2024 |
Molecule to Market: Our top trends 2023, part 1
|
Dec 29, 2023 |
Expert to Entrepreneur
|
Dec 15, 2023 |
The lab model of the future?
|
Dec 08, 2023 |
Look into 2024: Events Roundtable special
|
Dec 01, 2023 |
The problem-solving CMC consultant
|
Nov 24, 2023 |
Microsoft talks to Molecule to Market
|
Nov 17, 2023 |
Biopharma innovation in motion
|
Nov 10, 2023 |
Say hello to a “CTDMO”
|
Nov 03, 2023 |
The involuntary entrepreneur chemist
|
Oct 27, 2023 |
A passion for pharma packaging
|
Oct 20, 2023 |
M2M meets Moderna & CPHI Conversations
|
Oct 17, 2023 |
Launching a technology-forward CDMO
|
Oct 13, 2023 |
Designing facilities today for tomorrow’s medicines
|
Oct 06, 2023 |
The problem-solving biopharma veteran
|
Sep 29, 2023 |
The servant leader creating the next generation CDMO
|
Sep 22, 2023 |
From Powdersize to Microsize
|
Sep 15, 2023 |
The mission-driven biotech CEO
|
Sep 08, 2023 |
Foot on the pedal for Predictive Oncology
|
Sep 01, 2023 |
One-hour special: The biopharma outsourcer
|
Aug 25, 2023 |
From rural roots to global pharma leader
|
Aug 18, 2023 |
Igniting biotech innovation
|
Aug 11, 2023 |
From CDMO exit to CDMO+
|
Aug 04, 2023 |
From MBO to global, family-run CRO
|
Jul 28, 2023 |
Attracting and retaining the best talent; a roundtable special
|
Jul 21, 2023 |
Breathing life into high potential medicines
|
Jul 14, 2023 |
Molecule to Market is on the move...
|
Jul 12, 2023 |
Barbara’s journey into Biopharma
|
Jul 07, 2023 |
The CDMO CEO that doesn’t sugarcoat
|
Jun 30, 2023 |
Wheeler CDMO Avengers...assemble!
|
Jun 23, 2023 |
The future is bright, the future is CGT
|
Jun 16, 2023 |
The biopharma boss on a mission against mental health disorders
|
Jun 09, 2023 |
From semiconductors to life sciences
|
Jun 02, 2023 |
The CRO scientist turned entrepreneur
|
May 26, 2023 |
CDMO poacher turned biotech gamekeeper
|
May 19, 2023 |
Q123 M&A roundtable
|
May 12, 2023 |
Meet the future of bioreactors
|
May 05, 2023 |
Meet the lean, keen biotech
|
Apr 28, 2023 |
Why biotechs are feeling the bite
|
Apr 21, 2023 |
The Amalgamator of Biz and Bio
|
Apr 14, 2023 |
The 30-year biotech and CDMO entrepreneur
|
Apr 06, 2023 |
The ATMP and CDMO deal maker
|
Mar 31, 2023 |
From AZ to CRO Founder
|
Mar 24, 2023 |
The iterative nature of emerging therapeutics
|
Mar 17, 2023 |
Think Star Trek, Think Smart Labs
|
Mar 10, 2023 |
Founding and selling three bio CDMOs - Part 2
|
Mar 03, 2023 |
Founding and selling three bio CDMOs - Part 1
|
Feb 24, 2023 |
Network like a pro
|
Feb 17, 2023 |
Diversity in life sciences
|
Feb 10, 2023 |
The CDMO CEO on the frontline of a Covid mission
|
Feb 03, 2023 |
Industry insights you cannot afford to miss
|
Jan 27, 2023 |
The Puzzle-Solving Lifelong Science Geek
|
Jan 20, 2023 |
The CDMO with a capital D
|
Jan 13, 2023 |
100 episodes of Molecule to Market: looking back, lessons & laying the land for 101
|
Jan 06, 2023 |
Raman’s review of life science in 2022
|
Dec 29, 2022 |
A blast from the life science past
|
Dec 23, 2022 |
Tackling the 3 Big C’s: CDMO Career, Children & Cancer
|
Dec 16, 2022 |
Mystic Miller’s review of ’22 and predictions for ’23
|
Dec 09, 2022 |
Top 5 episodes of all time
|
Nov 18, 2022 |
CPHI 2022 - Trends, challenges & opportunities
|
Nov 11, 2022 |
Views from AAPS 2022
|
Oct 28, 2022 |
The Personalized Medicine Pioneer
|
Oct 21, 2022 |
Inizio’s biotech bromance
|
Oct 06, 2022 |
The Magic of Drug Development
|
Sep 29, 2022 |
Why everything starts with great culture
|
Sep 08, 2022 |
The orphan drug entrepreneur
|
Aug 12, 2022 |
The wonder of Wurster technology
|
Jul 22, 2022 |
Biotech trends you need to know
|
Jul 15, 2022 |
Biotech briefs
|
Jul 08, 2022 |
Africa’s biotech butterfly
|
Jun 27, 2022 |
The global pharma leader with an eye on societal impact
|
Jun 20, 2022 |
From PhD to Pioneer
|
Jun 17, 2022 |
Supply chain challenges and trends
|
Jun 10, 2022 |
Chats from CPhI North America
|
May 27, 2022 |
The BioPharmGuy
|
May 16, 2022 |
Chronicles of Swiss Biotech day
|
May 11, 2022 |
From CDMO builder to CDMO creator
|
May 04, 2022 |
Built in Boston, now rebuilding businesses
|
Apr 25, 2022 |
In the trenches of pharma manufacturing
|
Apr 22, 2022 |
From Sweden with Science
|
Apr 11, 2022 |
The niche, niche CDMO with enviable patient reach
|
Apr 06, 2022 |
Diaries of DCAT
|
Apr 06, 2022 |
Finland’s Viral Vector Manufacturer of Happinesses
|
Mar 01, 2022 |
From corporate rebel to CDMO entrepreneur
|
Feb 25, 2022 |
Mr digital transformation
|
Feb 17, 2022 |
The Latin American logistics leader
|
Feb 09, 2022 |
The opportunistic entrepreneur
|
Jan 31, 2022 |
The Floundering Founder, a lifetime of knowledge for as little as a pound/dollar.
|
Jan 25, 2022 |
From Pharmacy to $1B family-owned CDMO
|
Jan 24, 2022 |
Roundtable: M&A trends in CDMO
|
Jan 18, 2022 |
The UK’s hidden life science gem
|
Jan 10, 2022 |
Meet the potent powder expert
|
Dec 20, 2021 |
Physician. Scientist. Entrepreneur.
|
Dec 15, 2021 |
Hollywood DVDs to biotech drugs
|
Dec 10, 2021 |
The big pharma sourcing specialist
|
Nov 29, 2021 |
The Cleanroom Veteran
|
Nov 18, 2021 |
The 4Cs every CDMO vendor should know
|
Nov 15, 2021 |
What next for trade events?
|
Oct 15, 2021 |
The life science dating agent
|
Oct 04, 2021 |
A little, big announcement...
|
Sep 16, 2021 |
The CDMO start-up... with a heck of a track record
|
Sep 03, 2021 |
From Big Pharma to CDMO leader
|
Aug 12, 2021 |
The change optimist
|
Jul 15, 2021 |
The Public Health vaccine specialist
|
Jul 08, 2021 |
The academic turned biopharma innovator
|
Jun 30, 2021 |
From chemist to consultant
|
Jun 25, 2021 |
The unique general
|
May 20, 2021 |
The Stickability factor
|
May 12, 2021 |
Poacher turned gamekeeper, turned hybrid
|
Apr 30, 2021 |
The humble leader
|
Apr 21, 2021 |
The understated, elite vaccine scientist
|
Apr 14, 2021 |
Creating a healthy culture
|
Apr 01, 2021 |
40 at 40
|
Mar 25, 2021 |
From Pfizer to CDMO start-up
|
Mar 17, 2021 |
Expanding drug dosage possibilities…
|
Mar 10, 2021 |
From Teesside Uni to global leader
|
Mar 03, 2021 |
The accidental CDMO
|
Feb 22, 2021 |
The passionate problem solver
|
Feb 15, 2021 |
The entrepreneurial scientist
|
Feb 08, 2021 |
The sales guru
|
Jan 28, 2021 |
Marathons. Wine. And 30 years in healthcare.
|
Jan 21, 2021 |
The industry guru
|
Jan 14, 2021 |
10 Trends for 2021
|
Jan 08, 2021 |
The CDMO Disrupter
|
Dec 10, 2020 |
The biologic CDMO growth guy
|
Nov 24, 2020 |
Leading M&A at a top-5 global CDMO
|
Nov 20, 2020 |
The virotherapy virtuoso
|
Nov 13, 2020 |
Roundtable: Collaboration and driving efficiency
|
Oct 16, 2020 |
Roundtable: Latest trends in CDMO
|
Oct 15, 2020 |
Roundtable: Clinical trials in 2020 and beyond
|
Oct 15, 2020 |
Roundtable: Global geography and the pharma and bio supply chain
|
Oct 13, 2020 |
Scientist & champion powerlifter
|
Sep 29, 2020 |
From fax to SaaS: digitising the the pharma supply chain
|
Sep 22, 2020 |
Successful outsourcing partnerships: now and then
|
Sep 08, 2020 |
Old world solutions won’t work for new world problems
|
Aug 31, 2020 |
Looking towards the future: A continuous mindset
|
Aug 25, 2020 |
Life in a boutique, specialist CDMO
|
Aug 10, 2020 |
Owning your authenticity
|
Aug 03, 2020 |
Building robust and scalable systems
|
Jul 27, 2020 |
Entrepreneurship in the life science space
|
Jul 22, 2020 |
Advocating for the CDMO sector
|
Jul 20, 2020 |
The benefits of postponement packaging
|
Jul 15, 2020 |
Taking the family-owned CDMO global
|
Jul 13, 2020 |
The increasing demand for HPAPI
|
Jul 06, 2020 |
A CDMO on the Covid-19 frontline
|
Jul 01, 2020 |
Learnings from 30 years in the CDMO space
|
Jun 17, 2020 |
The importance of positive, disruptive thinking
|
Jun 15, 2020 |
The value of diversity In pharma
|
Jun 11, 2020 |
Life as a journalist in the space
|
May 20, 2020 |
What is driving the demand for spray drying?
|
May 20, 2020 |
A Generation of Pharma Entrepreneurs
|
May 20, 2020 |
Leading a top tier CDMO
|
May 20, 2020 |
Intro to molecule to market
|
Apr 20, 2020 |